Beyond Immunity: Challenges in Kidney Retransplantation Among Persons Living With HIV.

Disparities HCV HIV Kidney Retransplantation Transplantation

Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 01 03 2024
revised: 29 07 2024
accepted: 17 08 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 19 9 2024
Statut: aheadofprint

Résumé

While superb outcomes have been observed in the HIV-positive (HIV+) population, graft failure and subsequent need for kidney retransplantation (re-KT) remain a concern. This study aims to investigate the difference in success rates of re-KT allograft survival in the HIV+ versus HIV-negative (HIV-) population in the current era of transplantation (2014-2022). Data was collected from the Organ Procurement and Transplantation Network on all kidney transplant donors and recipients who had their first re-KT between 2014 and 2022. Allograft survival was assessed using Kaplan-Meier analysis with a log-rank test, while risk factors for graft loss were assessed using Cox proportional hazards with statistical significance set to P = 0.05. HIV+ recipients were significantly more likely to be Black (P < 0.001), have an HLA mismatch >3 (P = 0.018), delayed graft function (P = 0.023), and graft loss from primary nonfunction (P < 0.001). Their HIV- counterparts were more likely to be White (P < 0.001) and Hispanic (<0.001), lose their graft from acute rejection (P = 0.044), and have a living donor (P = 0.001). Being HIV+ was associated with a 1.68-fold increased risk of graft loss, an HLA mismatch >3 held a 1.18-fold increase, experiencing delayed graft function held a 1.89-fold increase, and having diabetes was associated with a 1.16-fold increased risk. Living donor kidneys were associated with a 15.8% decrease in risk for graft failure. Kaplan-Meier curves showed a significantly lower duration of kidney allograft survival in the HIV+ community (P = 0.02). Disproportional graft failure and inadequate HLA mismatching persist within the HIV+ Re-KT community. Stronger organ matching and new approaches for desensitizing retransplant candidates are vital.

Identifiants

pubmed: 39298938
pii: S0022-4804(24)00522-5
doi: 10.1016/j.jss.2024.08.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-56

Informations de copyright

Published by Elsevier Inc.

Auteurs

Dante A Puntiel (DA)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Tomas M Prudencio (TM)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Benjamin Peticca (B)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Brooke Stanicki (B)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Jacob Liss (J)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Nicolas Egan (N)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Antonio Di Carlo (A)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Kenneth Chavin (K)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania.

Sunil S Karhadkar (SS)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Surgery, Temple University Hospital, Philadelphia, Pennsylvania. Electronic address: sunil.karhadkar@temple.edu.

Classifications MeSH